Broad Institute, UC Berkeley fight CRISPR patent battle for untold $$$; hey IRS: where does nonprofit college end and for-profit business begin?






The News: The US Patent and Trademark Office (USPTO) on Wednesday (February 15, 2017) ruled in favor of the Broad Institute (Cambridge MA) of Harvard University and MIT regarding certain CRISPR-Cas9 patents,… Read more »

Humana bails Obamacare exchanges; signals beginning of the end of private insurer involvement






The News: Humana Inc. (Louisville KY) said it will leave the commercial individual insurance business effective in 2018, including coverage offered on public exchanges under the Affordable Care Act, after being unable to… Read more »

Teva reports 4Q earnings surprise; but 2017 guidance seen “through a glass darkly.”






The News: Teva Pharmaceutical Industries Ltd. (Petach Tikva ISR) reported Monday (February 13, 2017) that fourth-quarter sales surged 33% year-over-year to $6.5 billion, topping analysts’ estimates of $6.3 billion. The company… Read more »

Trump backs negotiating drug prices under Medicare; unless he doesn’t






The News: President Donald Trump supports Medicare drug price negotiations, his spokesman said last week, remarks that sent pharmaceutical stocks swinging again as investors tried to assess whether drugmakers will… Read more »

Federal judge blocks $54-billion Anthem, Cigna merger; judiciary giving notice who’s boss in court






The News: A federal judge last week (February 6, 2017) blocked health insurer Anthem Inc. (Indianapolis IN) from acquiring rival Cigna Corp. (Bloomfield CT), the second court ruling in recent… Read more »

Gilead’s slog downward accelerates; CEO’s growth reassurances need action–now






The News: Gilead Sciences Inc. (Foster City CA) on Tuesday (February 7, 2017) said that it anticipates full-year revenue for 2017 to be in the range of $22.5 billion to… Read more »

Express Scripts says prescription drug spending slowed in 2016; but compared to what, a speeding train?






The News: According to a recent report released by Express Scripts Holding Co. (St. Louis MO), the average list price of the most commonly used branded drugs in the US… Read more »

Trump and pharma execs make nice; what, Sen. Sanders too?






The News: Last week (January 30, 2017), President Trump promised some of the nation’s top drug-company executives in a meeting at the White House that he would shrink Food and… Read more »

Teva’s CEO Vigodman history; sudden departure calls for fearless successor






The News: Teva Pharmaceutical Industries Ltd. (Petach Tikva ISR) suddenly found itself without a permanent CEO on Tuesday (February 7, 2017) after Erez Vigodman stepped down, leaving new management to… Read more »